Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Race Oncology Ltd. ( (AU:RAC) ).
Race Oncology Ltd announced the issuance of 7,308 ordinary fully paid securities on May 7, 2025, as part of their application for quotation on the ASX. This move reflects the company’s ongoing efforts to enhance its financial standing and market presence, potentially impacting its operations and positioning within the biotechnology sector.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology industry, focusing on the development and commercialization of cancer therapies. They are primarily engaged in advancing their proprietary drug candidates to address unmet medical needs in oncology.
Average Trading Volume: 120,978
Technical Sentiment Signal: Sell
Current Market Cap: A$210.2M
Learn more about RAC stock on TipRanks’ Stock Analysis page.